MARKET

VNDA

VNDA

Vanda Pharma
NASDAQ
6.55
-0.89
-11.91%
Opening 10:14 02/12 EST
OPEN
7.15
PREV CLOSE
7.43
HIGH
7.15
LOW
6.52
VOLUME
810.62K
TURNOVER
--
52 WEEK HIGH
9.60
52 WEEK LOW
3.809
MARKET CAP
386.79M
P/E (TTM)
-4.5721
1D
5D
1M
3M
1Y
5Y
1D
Rollins Posts Downbeat Results, Joins Paycom Software, Cisco, Applovin And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Benzinga · 3h ago
Vanda Pharmaceuticals Files Prospectus For Offering Mixed Shelf; Terms Not Disclosed
Benzinga · 3h ago
Vanda Pharmaceuticals files $200M mixed securities shelf
TipRanks · 3h ago
VANDA PHARMACEUTICALS INC FILES FOR MIXED SHELF OFFERING OF UPTO $200 MLN - SEC FILING
Reuters · 3h ago
Vanda (VNDA) Q4 2025 Earnings Call Transcript
NASDAQ · 16h ago
Vanda Pharmaceuticals reports Q4 EPS ($2.39) vs. (8c) last year
TipRanks · 19h ago
Vanda Pharmaceuticals sees FY26 revenue $230M-$260M, consensus $271.27M
TipRanks · 19h ago
*Vanda Pharmaceuticals Sees FY26 Rev $230M-$260M >VNDA
Dow Jones · 19h ago
More
About VNDA
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of therapies to address unmet medical needs and improve the lives of patients. The Company’s commercial portfolio consist of three products: Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment of schizophrenia, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) and for the treatment of nighttime sleep disturbances in Smith-Magenis syndrome (SMS) and PONVORY for the treatment of relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease. In addition, it has a number of drugs and/or additional indications for current products in development, including Bysanti, Tradipitant, Imsidolimab, VTR-297, VQW-765, and others. Bysanti is the active metabolite of Fanapt.

Webull offers Vanda Pharmaceuticals Inc. stock information, including NASDAQ: VNDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VNDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VNDA stock methods without spending real money on the virtual paper trading platform.